A novel inhibitor-binding site on the HIV-1 capsid N-terminal domain leads to improved crystallization via compound-mediated dimerization.

MLA

Lemke, Christopher T., et al. “A Novel Inhibitor-Binding Site on the HIV-1 Capsid N-Terminal Domain Leads to Improved Crystallization via Compound-Mediated Dimerization.” Acta Crystallographica: Section D (Wiley-Blackwell), vol. 69, no. 6, June 2013, pp. 1115–23. EBSCOhost, https://doi.org/10.1107/S0907444913006409.

APA

Lemke, C. T., Titolo, S., Goudreau, N., Faucher, A.-M., Mason, S. W., & Bonneau, P. (2013). A novel inhibitor-binding site on the HIV-1 capsid N-terminal domain leads to improved crystallization via compound-mediated dimerization. Acta Crystallographica: Section D (Wiley-Blackwell), 69(6), 1115–1123. https://doi.org/10.1107/S0907444913006409

Chicago

Lemke, Christopher T., Steve Titolo, Nathalie Goudreau, Anne-Marie Faucher, Stephen W. Mason, and Pierre Bonneau. 2013. “A Novel Inhibitor-Binding Site on the HIV-1 Capsid N-Terminal Domain Leads to Improved Crystallization via Compound-Mediated Dimerization.” Acta Crystallographica: Section D (Wiley-Blackwell) 69 (6): 1115–23. doi:10.1107/S0907444913006409.